Published in Clin Exp Immunol on December 22, 2010
Profiles of responses of immunological factors to different subtypes of Kawasaki disease. BMC Musculoskelet Disord (2015) 0.81
A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease. PLoS One (2013) 0.81
Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility. Genes Immun (2015) 0.76
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol (2002) 7.60
Kawasaki syndrome. Lancet (2004) 5.09
Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol (2008) 3.61
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation (2006) 2.56
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev (2007) 2.22
IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis (2000) 1.58
Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol (2008) 1.56
Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol (1983) 1.46
IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol (1997) 1.44
Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr (1992) 1.40
Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol (1982) 1.24
Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol (2005) 1.21
Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol (2001) 1.16
New developments in the search for the etiologic agent of Kawasaki disease. Curr Opin Pediatr (2007) 1.14
Enumeration of IFN-gamma-producing human lymphocytes by spot-ELISA. A method to detect lymphokine-producing lymphocytes at the single-cell level. J Immunol Methods (1988) 1.07
The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis (2007) 1.04
Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin Exp Immunol (2009) 1.03
Pathogenesis and treatment of Kawasaki's disease. Curr Opin Rheumatol (2005) 1.01
Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Cardiovasc Pathol (1987) 0.97
Circulating interleukin 17 is increased in the acute stage of Kawasaki disease. Scand J Rheumatol (2003) 0.95
Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child (1992) 0.94
T cell activation profiles in Kawasaki syndrome. Clin Exp Immunol (2007) 0.89
Immunoregulatory changes in Kawasaki disease. Clin Immunol Immunopathol (1997) 0.84
Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease. Pediatr Res (2001) 0.84
The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies. Clin Exp Immunol (2002) 0.84
Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease. Yonsei Med J (2009) 0.83
[Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease]. Zhonghua Er Ke Za Zhi (2008) 0.81
Comparison of Kawasaki disease and infectious mononucleosis in terms of natural killer cell and CD8+ T cell subsets. J Infect Dis (1991) 0.81
Increased production of serum IgA-class antibody to lipid A in Kawasaki disease. Pediatr Int (2002) 0.79
Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease. Cell Immunol (2010) 0.77
[Change of MyD88-independent signal transduction of Toll-like receptor 4 in immunological pathogenesis of Kawasaki disease]. Zhonghua Er Ke Za Zhi (2007) 0.77
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ (2005) 2.91
Real-time detection of Helicobacter Pylori infection and atrophic gastritis: comparison between conventional methods and a novel device for gastric juice analysis during endoscopy. Endoscopy (2005) 1.97
IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol (1997) 1.61
Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. Arch Dermatol (1998) 1.59
Protective effect of N-acetylcysteine in tumor necrosis factor-alpha-induced apoptosis in U937 cells: the role of mitochondria. Exp Cell Res (1995) 1.57
Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch Biochem Biophys (1998) 1.54
CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J (2000) 1.45
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension. Hypertension (1990) 1.43
Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection. Eur J Immunol (1999) 1.35
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer (2000) 1.33
The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS. J Exp Med (1998) 1.30
Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization. Infect Immun (1990) 1.29
Distribution of human Class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res (1984) 1.26
Recommendations for airway control and difficult airway management. Minerva Anestesiol (2005) 1.24
Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features. J Cell Physiol (1990) 1.18
Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line. Cancer Res (1988) 1.16
Human immunodeficiency virus (HIV)-1 proteins and cytoskeleton: partners in viral life and host cell death. Cell Death Differ (2005) 1.15
Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett (2000) 1.15
The A3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-XL: studies in human astroglioma cells. Biochem Biophys Res Commun (1997) 1.10
Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry (1996) 1.10
Anandamide activates human platelets through a pathway independent of the arachidonate cascade. FEBS Lett (1999) 1.09
Respiratory syncytial virus lung infection in infants: immunoregulatory role of infected alveolar macrophages. J Infect Dis (1993) 1.08
Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells. J Immunol (2000) 1.06
Fanconi anaemia in Italy: high prevalence of complementation group A in two geographic clusters. Hum Genet (1996) 1.06
Toxin-induced activation of Rho GTP-binding protein increases Bcl-2 expression and influences mitochondrial homeostasis. Exp Cell Res (1998) 1.05
Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells. Mol Biol Cell (2001) 1.05
Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin. J Immunol (1988) 1.04
Tyrosol, the major olive oil biophenol, protects against oxidized-LDL-induced injury in Caco-2 cells. J Nutr (1999) 1.04
Role of ascorbate and protein thiols in the release of nitric oxide from S-nitroso-albumin and S-nitroso-glutathione in human plasma. Free Radic Biol Med (1997) 1.03
Lipid microdomains contribute to apoptosis-associated modifications of mitochondria in T cells. Cell Death Differ (2005) 1.03
Association of fission proteins with mitochondrial raft-like domains. Cell Death Differ (2010) 1.01
Transmembrane P-glycoprotein (P-gp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function. AIDS Res Hum Retroviruses (1995) 1.00
Lack of placebo effect on ambulatory blood pressure. Am J Hypertens (1995) 1.00
Death receptor ligation triggers membrane scrambling between Golgi and mitochondria. Cell Death Differ (2006) 1.00
IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production. J Leukoc Biol (2009) 0.99
Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica. Haematologica (2000) 0.99
Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals. Arch Biochem Biophys (1994) 0.99
Home care for chronic respiratory failure in children: 15 years experience. Paediatr Anaesth (2002) 0.98
Induction of apoptosis in caco-2 cells by wheat gliadin peptides. Toxicology (2000) 0.97
Epidemiology of pertussis in Italy: disease trends over the last century. Euro Surveill (2014) 0.96
Respiratory syncytial virus infection of alveolar macrophages in adult transplant patients. Am Rev Respir Dis (1992) 0.96
Recommendations for airway control and difficult airway management in paediatric patients. Minerva Anestesiol (2006) 0.96
HIV-1 gp120 accelerates Fas-mediated activation-induced human lamina propria T cell apoptosis. J Clin Immunol (1998) 0.96
Central serous chorioretinopathy and Helicobacter pylori. Eur J Ophthalmol (2006) 0.96
Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J (1999) 0.95
Restricted replication of respiratory syncytial virus in human alveolar macrophages. J Gen Virol (1993) 0.95
Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. Eur J Biochem (2001) 0.95
Coinfection in acute gastroenteritis predicts a more severe clinical course in children. Eur J Clin Microbiol Infect Dis (2013) 0.94
Hinderance of apoptosis and phagocytic behaviour induced by Escherichia coli cytotoxic necrotizing factor 1: two related activities in epithelial cells. Biochem Biophys Res Commun (1997) 0.94
C3-fullero-tris-methanodicarboxylic acid protects epithelial cells from radiation-induced anoikia by influencing cell adhesion ability. FEBS Lett (1999) 0.94
Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells. Oncogene (2000) 0.93
Rho-dependent cell spreading activated by E.coli cytotoxic necrotizing factor 1 hinders apoptosis in epithelial cells. Cell Death Differ (1998) 0.93
Xeno-cannibalism as an exacerbation of self-cannibalism: a possible fruitful survival strategy for cancer cells. Curr Pharm Des (2008) 0.93
Virus-induced alterations in macrophage production of tumor necrosis factor and prostaglandin E2. Am J Physiol (1990) 0.93
Suspected transmission of tuberculosis in a maternity ward from a smear-positive nurse: preliminary results of clinical evaluations and testing of neonates potentially exposed, Rome, Italy, 1 January to 28 July 2011. Euro Surveill (2011) 0.93
Interference with cell cycle progression and induction of apoptosis by dideoxynucleoside analogs. Int J Immunopharmacol (1997) 0.92
Induction of interleukin-15 production by HIV-1 nef protein: a role in the proliferation of uninfected cells. Exp Cell Res (1999) 0.92
Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor. Neurosci Lett (2001) 0.92
Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosis. J Invest Dermatol (2000) 0.92
Antigenic heterogeneity of skin tumors of nonmelanocyte origin: analysis with monoclonal antibodies to tumor-associated antigens and to histocompatibility antigens. J Natl Cancer Inst (1983) 0.91
Phenotypic characteristics and tendency to apoptosis of peripheral blood mononuclear cells from HIV+ long term non progressors. Cell Death Differ (1997) 0.91
The HIV-1 gp120 causes ultrastructural changes typical of apoptosis in the rat cerebral cortex. Neuroreport (1996) 0.90
Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways. Cell Growth Differ (1997) 0.90
A novel action for adenosine: apoptosis of astroglial cells in rat brain primary cultures. Biochem Biophys Res Commun (1995) 0.89
C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem Biophys Res Commun (2000) 0.89
HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclo-oxygenase type 2 (COX-2). Biochem Biophys Res Commun (1998) 0.89
Hydrogen peroxide has a role in the aggregation of human platelets. FEBS Lett (1985) 0.88
Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis. J Clin Endocrinol Metab (2000) 0.88
Sendai virus and herpes virus type 1 induce apoptosis in human peripheral blood mononuclear cells. Exp Cell Res (1995) 0.88
Involvement of interleukin-1beta in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat. Neuroscience (1999) 0.87
Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease. Neurobiol Aging (2010) 0.87
3-Aminobenzamide protects cells from UV-B-induced apoptosis by acting on cytoskeleton and substrate adhesion. Biochem Biophys Res Commun (1995) 0.87
Hydrogen peroxide release from human blood platelets. Biochim Biophys Acta (1982) 0.87
Morphological, histochemical and biochemical studies on germ cell mitochondria of normal rats. Cell Tissue Res (1979) 0.87
GD3 glycosphingolipid contributes to Fas-mediated apoptosis via association with ezrin cytoskeletal protein. FEBS Lett (2001) 0.87
Disseminated arthritis and osteitis by Candida albicans in a two month old infant receiving parenteral nutrition. Acta Paediatr Scand (1977) 0.87
N-Acetylcysteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease. Biochem Biophys Res Commun (2000) 0.87
C3-fullero-tris-methanodicarboxylic acid protects cerebellar granule cells from apoptosis. J Neurochem (2000) 0.86
N-acetylcysteine protects epithelial cells against the oxidative imbalance due to Clostridium difficile toxins. FEBS Lett (1999) 0.86
The highly reducing sugar 2-deoxy-D-ribose induces apoptosis in human fibroblasts by reduced glutathione depletion and cytoskeletal disruption. Biochem Biophys Res Commun (1998) 0.86
Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis. Biochem J (2001) 0.86
Validation of the SpaceLabs 90202 and 90207 devices for ambulatory blood pressure monitoring by comparison with intra-arterial resting and ambulatory measurements. J Hypertens Suppl (1991) 0.85
Gender disparity in pediatric diseases. Curr Mol Med (2013) 0.85
Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21. Eur Cytokine Netw (1998) 0.85
Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. Neuroscience (2010) 0.84
[Cannulation of the thoracic duct during central venous catheterization]. Minerva Anestesiol (1990) 0.84